Old | New | Differences | |
---|---|---|---|
1 | - | LAWRENCE J. HOGAN, JR., Governor Ch. 719 | |
2 | 1 | ||
3 | - | – 1 – | |
4 | - | Chapter 719 | |
5 | - | (House Bill 229) | |
6 | 2 | ||
7 | - | AN ACT concerning | |
3 | + | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. | |
4 | + | [Brackets] indicate matter deleted from existing law. | |
5 | + | Underlining indicates amendments to bill. | |
6 | + | Strike out indicates matter stricken from the bill by amendment or deleted from the law by | |
7 | + | amendment. | |
8 | + | *hb0229* | |
8 | 9 | ||
9 | - | Pharmacists – Administration of Maintenance Injectable Medications – | |
10 | - | Medications for Treatment of Sexually Transmitted Infections | |
10 | + | HOUSE BILL 229 | |
11 | + | J2, J1 2lr1027 | |
12 | + | CF SB 19 | |
13 | + | By: Delegates K. Young, Belcastro, Forbes, Healey, McComas, Reznik, and Ruth | |
14 | + | Introduced and read first time: January 13, 2022 | |
15 | + | Assigned to: Health and Government Operations | |
16 | + | Committee Report: Favorable with amendments | |
17 | + | House action: Adopted | |
18 | + | Read second time: March 2, 2022 | |
11 | 19 | ||
12 | - | FOR the purpose of altering the definition of “maintenance injectable medication” for the | |
13 | - | purposes of provisions of law governing the administration of maintenance injectable | |
14 | - | medications by pharmacists to include a medication that treats a sexually | |
15 | - | transmitted infection and is not a vaccine defining “injectable medications for | |
16 | - | treatment of sexually transmitted infections” for the purposes of authorizing | |
17 | - | pharmacists to administer the medications; requiring certain insurers, nonprofit | |
18 | - | health service plans, health maintenance organizations, the Maryland Medical | |
19 | - | Assistance Program, and the Maryland Children’s Health Program to provide certain | |
20 | - | coverage for the administration of the medication by a pharmacist; and generally | |
21 | - | relating to the administration of maintenance injectable medications by | |
22 | - | pharmacists. | |
20 | + | CHAPTER ______ | |
23 | 21 | ||
24 | - | BY repealing and reenacting, with amendments, | |
25 | - | Article – Health Occupations | |
26 | - | Section 12–101(o–1) | |
27 | - | Annotated Code of Maryland | |
28 | - | (2021 Replacement Volume) | |
22 | + | AN ACT concerning 1 | |
29 | 23 | ||
30 | - | BY repealing and reenacting, with amendments, | |
31 | - | Article – Health – General | |
32 | - | Section 15–148(c) | |
33 | - | Annotated Code of Maryland | |
34 | - | (2019 Replacement Volume and 2021 Supplement) | |
24 | + | Pharmacists – Administration of Maintenance Injectable Medications – 2 | |
25 | + | Medications for Treatment of Sexually Transmitted Infections 3 | |
35 | 26 | ||
36 | - | BY adding to | |
37 | - | Article – Health Occupations | |
38 | - | Section 12–101(l–1) | |
39 | - | Annotated Code of Maryland | |
40 | - | (2021 Replacement Volume) | |
27 | + | FOR the purpose of altering the definition of “maintenance injectable medication” for the 4 | |
28 | + | purposes of provisions of law governing the administration of maintenance injectable 5 | |
29 | + | medications by pharmacists to include a medication that treats a sexually 6 | |
30 | + | transmitted infection and is not a vaccine defining “injectable medications for 7 | |
31 | + | treatment of sexually transmitted infections” for the purposes of authorizing 8 | |
32 | + | pharmacists to administer the medications; requiring certain insurers, nonprofit 9 | |
33 | + | health service plans, health maintenance organizations, the Maryland Medical 10 | |
34 | + | Assistance Program, and the Maryland Children’s Health Program to provide certain 11 | |
35 | + | coverage for the administration of the medication by a pharmacist; and generally 12 | |
36 | + | relating to the administration of maintenance injectable medications by 13 | |
37 | + | pharmacists. 14 | |
41 | 38 | ||
42 | - | BY repealing and reenacting, | |
43 | - | Article – Health Occupations | |
44 | - | Section 12– | |
45 | - | Annotated Code of Maryland | |
46 | - | (2021 Replacement Volume) | |
39 | + | BY repealing and reenacting, with amendments, 15 | |
40 | + | Article – Health Occupations 16 | |
41 | + | Section 12–101(o–1) 17 | |
42 | + | Annotated Code of Maryland 18 | |
43 | + | (2021 Replacement Volume) 19 | |
47 | 44 | ||
48 | - | BY repealing and reenacting, with amendments, | |
49 | - | Article – Insurance Ch. 719 2022 LAWS OF MARYLAND | |
45 | + | BY repealing and reenacting, with amendments, 20 | |
46 | + | Article – Health – General 21 | |
47 | + | Section 15–148(c) 22 | |
48 | + | Annotated Code of Maryland 23 2 HOUSE BILL 229 | |
50 | 49 | ||
51 | - | – 2 – | |
52 | - | Section 15–716 | |
53 | - | Annotated Code of Maryland | |
54 | - | (2017 Replacement Volume and 2021 Supplement) | |
55 | 50 | ||
56 | - | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, | |
57 | - | That the Laws of Maryland read as follows: | |
51 | + | (2019 Replacement Volume and 2021 Supplement) 1 | |
58 | 52 | ||
59 | - | Article – Health – General | |
53 | + | BY adding to 2 | |
54 | + | Article – Health Occupations 3 | |
55 | + | Section 12–101(l–1) 4 | |
56 | + | Annotated Code of Maryland 5 | |
57 | + | (2021 Replacement Volume) 6 | |
60 | 58 | ||
61 | - | 15–148. | |
59 | + | BY repealing and reenacting, without with amendments, 7 | |
60 | + | Article – Health Occupations 8 | |
61 | + | Section 12–509(a) and (b) 12–509 9 | |
62 | + | Annotated Code of Maryland 10 | |
63 | + | (2021 Replacement Volume) 11 | |
62 | 64 | ||
63 | - | (c) The Program and the Maryland Children’s Health Program shall provide | |
64 | - | coverage for services, to the same extent as services rendered by any other licensed health | |
65 | - | care practitioner, rendered to an enrollee by a licensed pharmacist under: | |
65 | + | BY repealing and reenacting, with amendments, 12 | |
66 | + | Article – Insurance 13 | |
67 | + | Section 15–716 14 | |
68 | + | Annotated Code of Maryland 15 | |
69 | + | (2017 Replacement Volume and 2021 Supplement) 16 | |
66 | 70 | ||
67 | - | (1) § 12–509 of the Health Occupations Article in administering | |
68 | - | self–administered medications [or], maintenance injectable medications, OR INJECTABLE | |
69 | - | MEDICATIONS FOR TREA TMENT OF SEXUALLY TRANSMIT TED INFECTIONS ; or | |
71 | + | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLA ND, 17 | |
72 | + | That the Laws of Maryland read as follows: 18 | |
70 | 73 | ||
71 | - | (2) § 12–511 of the Health Occupations Article in screening an enrollee and | |
72 | - | prescribing contraceptives for the enrollee. | |
74 | + | Article – Health – General 19 | |
73 | 75 | ||
74 | - | ||
76 | + | 15–148. 20 | |
75 | 77 | ||
76 | - | 12–101. | |
78 | + | (c) The Program and the Maryland Children’s Health Program shall provide 21 | |
79 | + | coverage for services, to the same extent as services rendered by any other licensed health 22 | |
80 | + | care practitioner, rendered to an enrollee by a licensed pharmacist under: 23 | |
77 | 81 | ||
78 | - | (o–1) (1) “Maintenance injectable medication” means a medication that: | |
82 | + | (1) § 12–509 of the Health Occupations Article in administering 24 | |
83 | + | self–administered medications [or], maintenance injectable medications, OR INJECTABLE 25 | |
84 | + | MEDICATIONS FOR TREA TMENT OF SEX UALLY TRANSMITTED IN FECTIONS; or 26 | |
79 | 85 | ||
80 | - | (i) Is administered by injection other than intravenously; and | |
86 | + | (2) § 12–511 of the Health Occupations Article in screening an enrollee and 27 | |
87 | + | prescribing contraceptives for the enrollee. 28 | |
81 | 88 | ||
82 | - | ||
89 | + | Article – Health Occupations 29 | |
83 | 90 | ||
84 | - | 2. TREATS A SEXUALLY TRA NSMITTED INFECTION A ND | |
85 | - | IS NOT A VACCINE . | |
91 | + | 12–101. 30 | |
86 | 92 | ||
87 | - | (2) “Maintenance injectable medication” includes a medication for the | |
88 | - | treatment of a psychiatric disorder or substance use disorder, contraception, and vitamins. | |
93 | + | (o–1) (1) “Maintenance injectable medication” means a medication that: 31 | |
89 | 94 | ||
90 | - | (L–1) “INJECTABLE MEDICATION FOR TREATMENT OF A S EXUALLY | |
91 | - | TRANSMITTED INFECTIO N” MEANS A MEDICATION T HAT: | |
95 | + | (i) Is administered by injection other than intravenously; and 32 | |
92 | 96 | ||
93 | - | ( | |
97 | + | (ii) 1. Treats a chronic need, condition, or disorder; OR 33 HOUSE BILL 229 3 | |
94 | 98 | ||
95 | - | (2) TREATS A SEXUALLY TRA NSMITTED INFECTION ; AND | |
96 | - | LAWRENCE J. HOGAN, JR., Governor Ch. 719 | |
97 | 99 | ||
98 | - | – 3 – | |
99 | - | (3) IS NOT A VACCINE. | |
100 | 100 | ||
101 | - | 12–509. | |
101 | + | 2. TREATS A SEXUALLY TRA NSMITTED INFECTION A ND 1 | |
102 | + | IS NOT A VACCINE. 2 | |
102 | 103 | ||
103 | - | (a) In addition to the authority granted to a pharmacist under § 12–508 of this | |
104 | - | subtitle, a pharmacist, in accordance with regulations adopted by the Board, may | |
105 | - | administer: | |
104 | + | (2) “Maintenance injectable medication” includes a medication for the 3 | |
105 | + | treatment of a psychiatric disorder or substance use disorder, contraception, and vitamins. 4 | |
106 | 106 | ||
107 | - | (1) | |
108 | - | ||
107 | + | (L–1) “INJECTABLE MEDICATION FOR TREATMENT OF A S EXUALLY 5 | |
108 | + | TRANSMITTED INFECTIO N” MEANS A MEDICATION T HAT: 6 | |
109 | 109 | ||
110 | - | (2) Subject to subsection (b) of this section, a maintenance injectable | |
111 | - | medication OR AN INJEC TABLE MEDICATION FOR TREATMENT OF A SEXUA LLY | |
112 | - | TRANSMITTED INFECTIO N that is not a biological product to a patient: | |
110 | + | (1) IS ADMINISTERED BY IN JECTION OTHER THAN I NTRAVENOUSLY ; 7 | |
113 | 111 | ||
114 | - | ( | |
112 | + | (2) TREATS A SEXUALLY TRA NSMITTED INFECTION ; AND 8 | |
115 | 113 | ||
116 | - | (ii) In accordance with a standing order issued by an authorized | |
117 | - | public health official; or | |
114 | + | (3) IS NOT A VACCINE. 9 | |
118 | 115 | ||
119 | - | ||
116 | + | 12–509. 10 | |
120 | 117 | ||
121 | - | (b) A pharmacist may not administer an initial dose of a maintenance injectable | |
122 | - | medication product OR AN INJECTABLE MED ICATION FOR TREATMEN T OF A SEXUALLY | |
123 | - | TRANSMITTED INFE CTION under subsection (a)(2) of this section unless the pharmacist | |
124 | - | receives written approval from the prescriber. | |
118 | + | (a) In addition to the authority granted to a pharmacist under § 12–508 of this 11 | |
119 | + | subtitle, a pharmacist, in accordance with regulations adopted by the Board, may 12 | |
120 | + | administer: 13 | |
125 | 121 | ||
126 | - | (c) (1) On or before September 1, 2021, the Board, in consultation with the | |
127 | - | State Board of Physicians and the State Board of Nursing, shall adopt regulations | |
128 | - | establishing standard procedures: | |
122 | + | (1) A self–administered drug to a patient that is prescribed by an 14 | |
123 | + | authorized prescriber; and 15 | |
129 | 124 | ||
130 | - | ( | |
131 | - | ||
132 | - | ||
125 | + | (2) Subject to subsection (b) of this section, a maintenance injectable 16 | |
126 | + | medication OR AN INJECTABLE MEDICATION FOR TREATMENT OF A S EXUALLY 17 | |
127 | + | TRANSMITTED INFECTIO N that is not a biological product to a patient: 18 | |
133 | 128 | ||
134 | - | ( | |
129 | + | (i) That is prescribed by an authorized prescriber; 19 | |
135 | 130 | ||
136 | - | | |
137 | - | ||
131 | + | (ii) In accordance with a standing order issued by an authorized 20 | |
132 | + | public health official; or 21 | |
138 | 133 | ||
139 | - | 2. AN INJECTABLE MEDICAT ION FOR TREATMENT OF A | |
140 | - | SEXUALLY TRANSMITTED INFECTION; | |
134 | + | (iii) In accordance with a protocol under Subtitle 6A of this title. 22 | |
141 | 135 | ||
142 | - | (iii) That a pharmacist must use to administer an initial dose of a | |
143 | - | maintenance injectable medication OR AN INJECTABLE MED ICATION FOR TREATMEN T Ch. 719 2022 LAWS OF MARYLAND | |
136 | + | (b) A pharmacist may not administer an initial dose of a maintenance injectable 23 | |
137 | + | medication product OR AN INJECTABLE MED ICATION FOR TREATMEN T OF A SEXUALLY 24 | |
138 | + | TRANSMITTED INFECTION under subsection (a)(2) of this section unless the pharmacist 25 | |
139 | + | receives written approval from the prescriber. 26 | |
144 | 140 | ||
145 | - | – 4 – | |
146 | - | OF A SEXUALLY TRANSM ITTED INFECTION if the administration of the initial dose is | |
147 | - | authorized under subsection (b) of this section; and | |
141 | + | (c) (1) On or before September 1, 2021, the Board, in consultation with the 27 | |
142 | + | State Board of Physicians and the State Board of Nursing, shall adopt regulations 28 | |
143 | + | establishing standard procedures: 29 | |
144 | + | 4 HOUSE BILL 229 | |
148 | 145 | ||
149 | - | (iv) For communicating to the prescriber whether a medication was | |
150 | - | administered to a specific patient and relevant information about the patient’s condition. | |
151 | 146 | ||
152 | - | (2) The regulations shall require a pharmacist to: | |
147 | + | (i) For notifying a patient about payment for services before the 1 | |
148 | + | pharmacist administers a maintenance injectable medication OR AN INJECTABLE 2 | |
149 | + | MEDICATION FOR TREAT MENT OF A SEXUALLY T RANSMITTED INFECTION; 3 | |
153 | 150 | ||
154 | - | (i) Except as provided in paragraph (3) of this subsection, complete | |
155 | - | a training program approved by the Board for: | |
151 | + | (ii) That a pharmacist must use to administer [a]: 4 | |
156 | 152 | ||
157 | - | 1. Administering maintenance injectable medications AND | |
158 | - | INJECTABLE MEDICATIO NS FOR TREATMENT OF A SEXUALLY TRANSMITT ED | |
159 | - | INFECTION; and | |
153 | + | 1. A maintenance injectable medication after an initial dose 5 | |
154 | + | is administered by the prescriber; OR 6 | |
160 | 155 | ||
161 | - | 2. Managing the populations the pharmacist serves, the | |
162 | - | medications being administered, and the current guidelines relating to these populations | |
163 | - | and medications; | |
156 | + | 2. AN INJECTABLE MEDICAT ION FOR TREATMENT OF A 7 | |
157 | + | SEXUALLY TRANSMITTED INFECTION; 8 | |
164 | 158 | ||
165 | - | (ii) Follow the standard procedures established by the Board; and | |
159 | + | (iii) That a pharmacist must use to administer an initial dose of a 9 | |
160 | + | maintenance injectable medication OR AN INJECTABLE MED ICATION FOR TREATMEN T 10 | |
161 | + | OF A SEXUALLY TRANSM ITTED INFECTION if the administration of the initial dose is 11 | |
162 | + | authorized under subsection (b) of this section; and 12 | |
166 | 163 | ||
167 | - | (iii) After administering a maintenance injectable medication OR AN | |
168 | - | INJECTABLE MEDICATIO N FOR TREATMENT OF A SEXUALLY TRANSMITTED | |
169 | - | INFECTION: | |
164 | + | (iv) For communicating to the prescriber whether a medication was 13 | |
165 | + | administered to a specific patient and relevant information about the patient’s condition. 14 | |
170 | 166 | ||
171 | - | 1. Notify the prescriber that the maintenance injectable | |
172 | - | medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A SEXUALLY | |
173 | - | TRANSMITTED INFECTIO N was administered and of any relevant details about the | |
174 | - | patient’s condition; | |
167 | + | (2) The regulations shall require a pharmacist to: 15 | |
175 | 168 | ||
176 | - | 2. Provide the patient with a written record of the | |
177 | - | maintenance injectable medication OR INJECTABLE MEDICATION FOR TREAT MENT OF | |
178 | - | A SEXUALLY TRANSMITT ED INFECTION administered; | |
169 | + | (i) Except as provided in paragraph (3) of this subsection, complete 16 | |
170 | + | a training program approved by the Board for: 17 | |
179 | 171 | ||
180 | - | 3. Record in any electronic or written health record on the | |
181 | - | patient maintained by the pharmacist: | |
172 | + | 1. Administering maintenance injectable medications AND 18 | |
173 | + | INJECTABLE MEDICATIO NS FOR TREATMENT OF A SEXUALLY TRANSMITT ED 19 | |
174 | + | INFECTION; and 20 | |
182 | 175 | ||
183 | - | | |
184 | - | ||
185 | - | ||
176 | + | 2. Managing the populations the pharmacist serves, the 21 | |
177 | + | medications being administered, and the current guidelines relating to these populations 22 | |
178 | + | and medications; 23 | |
186 | 179 | ||
187 | - | | |
180 | + | (ii) Follow the standard procedures established by the Board; and 24 | |
188 | 181 | ||
189 | - | 4. Notify the patient of the need to attend any upcoming | |
190 | - | appointments the patient has scheduled with the prescriber. LAWRENCE J. HOGAN, JR., Governor Ch. 719 | |
182 | + | (iii) After administering a maintenance injectable medication OR AN 25 | |
183 | + | INJECTABLE MEDICATIO N FOR TREATMENT OF A SEXUALLY TRANSMITTED 26 | |
184 | + | INFECTION: 27 | |
191 | 185 | ||
192 | - | – 5 – | |
186 | + | 1. Notify the prescriber that the maintenance injectable 28 | |
187 | + | medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A SEXU ALLY 29 | |
188 | + | TRANSMITTED INFECTIO N was administered and of any relevant details about the 30 | |
189 | + | patient’s condition; 31 | |
190 | + | HOUSE BILL 229 5 | |
193 | 191 | ||
194 | - | (3) The regulations shall waive the requirement to complete a training | |
195 | - | program for a pharmacist who already has undergone the training as part of the | |
196 | - | pharmacist’s formal educational program. | |
197 | 192 | ||
198 | - | Article – Insurance | |
193 | + | 2. Provide the patient with a written record of the 1 | |
194 | + | maintenance injectable medication OR INJECTABLE MEDICA TION FOR TREATMENT O F 2 | |
195 | + | A SEXUALLY TRANSMITT ED INFECTION administered; 3 | |
199 | 196 | ||
200 | - | 15–716. | |
197 | + | 3. Record in any electronic or written health record on the 4 | |
198 | + | patient maintained by the pharmacist: 5 | |
201 | 199 | ||
202 | - | (a) This section applies to individual, group, or blanket health insurance policies | |
203 | - | and contracts delivered or issued for delivery in the State by insurers, nonprofit health | |
204 | - | service plans, and health maintenance organizations that provide coverage for patient | |
205 | - | assessment regarding, and administration of, self–administered medications [and], | |
206 | - | maintenance injectable medications, AND INJECTABLE MEDIC ATIONS FOR TREATMENT | |
207 | - | OF SEXUALLY TRANSMIT TED INFECTIONS . | |
200 | + | A. The administering of the maintenance injectable 6 | |
201 | + | medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A SEXUALLY 7 | |
202 | + | TRANSMITTED INFECTION ; and 8 | |
208 | 203 | ||
209 | - | (b) An entity subject to this section shall provide coverage for services rendered | |
210 | - | by a licensed pharmacist under § 12–509 of the Health Occupations Article to an individual | |
211 | - | who is covered under a policy or contract issued or delivered by the entity, to the same | |
212 | - | extent as services rendered by any other licensed health care practitioner, for patient | |
213 | - | assessment regarding and in administering self –administered medications [or], | |
214 | - | maintenance injectable medications, OR INJECTABLE MEDICA TIONS FOR TREATMENT | |
215 | - | OF SEXUALLY TRANSMIT TED INFECTIONS . | |
204 | + | B. Any pertinent details about the patient’s condition; and 9 | |
216 | 205 | ||
217 | - | SECTION 2. AND BE IT FURTHER ENACTED, That, to the extent determined | |
218 | - | appropriate by the State Board of Pharmacy, the regulations adopted by the State Board of | |
219 | - | Pharmacy, in consultation with the State Board of Physicians and the State Board of | |
220 | - | Nursing, under § 12–509 of the Health Occupations Article, as enacted by Chapters 757 | |
221 | - | and 758 of the Acts of 2021, for the administration of maintenance injectable medications | |
222 | - | by a pharmacist shall be the same regulations for the administration of injectable | |
223 | - | medications for treatment of sexually transmitted infections by a pharmacist adopted in | |
224 | - | accordance with § 12–509 of the Health Occupations Article, as enacted by this Act. | |
206 | + | 4. Notify the patient of the need to attend any upcoming 10 | |
207 | + | appointments the patient has scheduled with the prescriber. 11 | |
225 | 208 | ||
226 | - | SECTION 2. 3. AND BE IT FURTHER ENACTED, That this Act shall take effect | |
227 | - | October 1, 2022. | |
209 | + | (3) The regulations shall waive the requirement to complete a training 12 | |
210 | + | program for a pharmacist who already has undergone the training as part of the 13 | |
211 | + | pharmacist’s formal educational program. 14 | |
228 | 212 | ||
229 | - | Enacted under Article II, § 17(c) of the Maryland Constitution, May 29, 2022. | |
213 | + | Article – Insurance 15 | |
214 | + | ||
215 | + | 15–716. 16 | |
216 | + | ||
217 | + | (a) This section applies to individual, group, or blanket health insurance policies 17 | |
218 | + | and contracts delivered or issued for delivery in the State by insurers, nonprofit health 18 | |
219 | + | service plans, and health maintenance organizations that provide coverage for patient 19 | |
220 | + | assessment regarding, and administration of, self–administered medications [and], 20 | |
221 | + | maintenance injectable medications, AND INJECTABLE MEDIC ATIONS FOR TREATMENT 21 | |
222 | + | OF SEXUALLY TRANSMIT TED INFECTIONS . 22 | |
223 | + | ||
224 | + | (b) An entity subject to this section shall provide coverage for services rendered 23 | |
225 | + | by a licensed pharmacist under § 12–509 of the Health Occupations Article to an individual 24 | |
226 | + | who is covered under a policy or contract issued or delivered by the entity, to the same 25 | |
227 | + | extent as services rendered by any other licensed health care practitioner, for patient 26 | |
228 | + | assessment regarding and in administering self –administered medications [or], 27 | |
229 | + | maintenance injectable medications, OR INJECTABLE MEDICA TIONS FOR TREATMENT 28 | |
230 | + | OF SEXUALLY TRANSMIT TED INFECTIONS . 29 | |
231 | + | ||
232 | + | SECTION 2. AND BE IT FURTHER ENACTED, That, to the extent determined 30 | |
233 | + | appropriate by the State Board of Pharmacy, the regulations adopted by the State Board of 31 | |
234 | + | Pharmacy, in consultation with the State Board of Physicians and the State Board of 32 | |
235 | + | Nursing, under § 12–509 of the Health Occupations Article, as enacted by Chapters 757 33 | |
236 | + | and 758 of the Acts of 2021, for the administration of maintenance injectable medications 34 | |
237 | + | by a pharmacist shall be the same regulations for the administration of injectable 35 6 HOUSE BILL 229 | |
238 | + | ||
239 | + | ||
240 | + | medications for treatment of sexually transmitted infections by a pharmacist adopted in 1 | |
241 | + | accordance with § 12–509 of the Health Occupations Article, as enacted by this Act. 2 | |
242 | + | ||
243 | + | SECTION 2. 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 3 | |
244 | + | October 1, 2022. 4 | |
245 | + | ||
246 | + | ||
247 | + | ||
248 | + | ||
249 | + | Approved: | |
250 | + | ________________________________________________________________________________ | |
251 | + | Governor. | |
252 | + | ________________________________________________________________________________ | |
253 | + | Speaker of the House of Delegates. | |
254 | + | ________________________________________________________________________________ | |
255 | + | President of the Senate. |